Bank of Montreal
LPCN icon

Bank of Montreal’s Lipocine LPCN Stock Holding History

Bank of Montreal’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15
Closed – – 4379
2021
Q1 		$0 Buy
+15
New +$433 ﹤0.01% 5242

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of Montreal's LPCN Position: Q2 2021 in Review

Bank of Montreal sold out of Lipocine (LPCN) in Q2 2021, closing a stake of 15 shares.

Bank of Montreal first reported a position in LPCN in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 32 funds tracked by Wall St. Rank hold LPCN as of Q2 2021.

  • Bank of Montreal reported no remaining Lipocine position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 15 Lipocine shares in Q2 2021.
  • Bank of Montreal first reported a position in Lipocine in Q1 2021 and held it in 1 quarter.
  • Bank of Montreal's Lipocine position peaked at $0 in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Lipocine as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.